Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Cutaneous Systemic Sclerosis”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Early research (Phase 1)Active Not RecruitingNCT06152172
What this trial is testing

CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101

Who this might be right for
Idiopathic Inflammatory MyopathiesDiffuse Cutaneous Systemic SclerosisSLE Nephritis+1 more
David Porter 24
Not applicableStudy completedNCT04411498
What this trial is testing

Effects of Fibromyalgia Syndrome in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisFibromyalgia
Antalya Training and Research Hospital 140
Testing effectiveness (Phase 2)Study completedNCT04440592
What this trial is testing

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Tanabe Pharma America, Inc. 76
Not applicableLooking for participantsNCT06387654
What this trial is testing

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Who this might be right for
Autoimmune Bullous DermatosisDysimmune Dermatological DiseasesAuto-inflammatory Dermatological Diseases+1 more
University Hospital, Toulouse 800
Early research (Phase 1)Study completedNCT02426229
What this trial is testing

Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma

Who this might be right for
SclerodermaInterstitial Lung Disease
Medical University of South Carolina 15
Testing effectiveness (Phase 2)Study completedNCT03198689
What this trial is testing

Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Not applicableStudy completedNCT00513591
What this trial is testing

Duke Autoimmunity in Pregnancy Registry

Who this might be right for
PregnancySystemic Lupus ErythematosusCutaneous Lupus+3 more
Duke University 513
Testing effectiveness (Phase 2)Study completedNCT03274076
What this trial is testing

Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Who this might be right for
Systemic SclerosisScleroderma
University of Michigan 15
Testing effectiveness (Phase 2)Looking for participantsNCT05149768
What this trial is testing

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Post-approval studies (Phase 4)Ended earlyNCT03388255
What this trial is testing

Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases

Who this might be right for
Scleroderma Disease
Mastelli S.r.l 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06400303
What this trial is testing

KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis

Who this might be right for
Systemic SclerosisSystemic Sclerosis - Diffuse CutaneousSystemic Sclerosis - 2013 ACR/EULAR Classification Criteria
Kyverna Therapeutics 3
Not applicableStudy completedNCT01758250
What this trial is testing

Microvascular and Fibrosis Imaging Study

Who this might be right for
Autoimmune DiseasesSickle Cell DiseaseChronic Graft Versus Host Disease
Duke University 63
Testing effectiveness (Phase 2)Study completedNCT01538719
What this trial is testing

IL1-TRAP, Rilonacept, in Systemic Sclerosis

Who this might be right for
SclerodermaSystemic SclerosisDiffuse Scleroderma+1 more
Boston University 24
Early research (Phase 1)Not Yet RecruitingNCT06708845
What this trial is testing

US Zamto-cel Autoimmune Diseases

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSystemic Sclerosis (SSc)+1 more
Miltenyi Biomedicine GmbH 48
Testing effectiveness (Phase 2)Study completedNCT01651143
What this trial is testing

Proof of Biological Activity of SAR100842 in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Sanofi 32
Testing effectiveness (Phase 2)Looking for participantsNCT06470048
What this trial is testing

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Looking for participantsNCT06655896
What this trial is testing

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, Diffuse
Novartis Pharmaceuticals 96
Testing effectiveness (Phase 2)Ended earlyNCT03740724
What this trial is testing

FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)

Who this might be right for
MorpheaScleroderma, LocalizedScleroderma
Castle Creek Biosciences, LLC. 1
Testing effectiveness (Phase 2)Study completedNCT01670565
What this trial is testing

Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Hospital for Special Surgery, New York 20
Early research (Phase 1)Active Not RecruitingNCT06255028
What this trial is testing

CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisIdiopathic Inflammatory Myopathies+1 more
Century Therapeutics, Inc. 6
Load More Results